Eleonora Ghisoni: Discussing “Improving the management of immune-related toxicities” ESMO24
Eleonora Ghisoni posted on LinkedIn:
“Less than one week to ESMO24
Join us on Monday 16th to discuss about ‘Improving the management of immune-related toxicities’
Treatment beyond corticosteroids and a focus on myocardial and GI toxicities but also to not forget long-term side effects and impact on patients’ QoL!
Mario Mandalà, Evandro de Azambuja, Christina H. Ruhlmann Looking forward to see you in Barcelona!”
Evandro de Azambuja shared this post adding:
“A well thought session discussing immune-related toxicities at ESMO24.”
Source: Eleonora Ghisoni/LinkedIn and Evandro de Azambuja/LinkedIn
Evandro de Azambuja is the Director of Membership for the European Society for Medical Oncology (ESMO) for the 2023-2024 term and the President of the Belgian Society of Medical Oncology (BSMO) from 2023 to 2026. He leads the Medical Support Team at the Jules Bordet Institute, previously known as the BREAST Data Centre. He has an extensive background in clinical research, particularly in breast cancer and clinical trials.
Dr. Eleonora Ghisoni holds a PhD in Medicine and Life Sciences and is affiliated with Ludwig Cancer Research. She currently serves as a Chief Resident at Lausanne University Hospital (CHUV).
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023